Second-line FOLFOX chemotherapy for patients with advanced biliary tract cancers pretreated with cisplatin/gemcitabine: a systematic review and meta-analysis

Overview of attention for article published in ESMO Gastrointestinal Oncology, April 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#9 of 105)
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 34 X users

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 34 X posts from 34 X users, with an upper bound of 50,641 followers.

RT @ArndtVogel: 2nd line FOLFOX for biliary tract cancers pretreated with cisplatin/gemcitabine @ESMO_Open https://t.co/2E9esLIZWK 🔎system…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 30 additional X posts.